CClinicalTrials.gg
CompletedNCT02870114Updated May 24, 2017

National Survey of People With Haemophilia in Portugal

An observational study in Haemophilia, sponsored by University of Minho. Completed at 1 site in Portugal. Per ClinicalTrials.gov, last updated 2017-05-24.

Sponsored by University of Minho · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
146
Sex
All
01

Study summary

The purpose of this study is to implement a national survey to collect information regarding Portuguese people with haemophilia (PWH) on socio-demographic, clinical and psychosocial factors.

Read the detailed description

This is a cross-sectional design investigation focused on the socio-demographic, clinical and psychosocial characterization of Portuguese people with haemophilia (PWH). All PWH, registered in the Portuguese Hemophilia Association (APH) will be identified in APH registries and contacted through mail, in order to be invited to participate in the first Portuguese survey on haemophilia. In case of acceptance, patients must sign the Informed Consent, fill in the questionnaires and send both back to the investigation team through a pre-paid envelope in the national mail system.

PWH of all ages are invited to participate in this survey. Adults (aged 18 and over) and children/youth from 10 to 17 will answer the questionnaires by self report. Parents of small children (0 to 9) will fill in the proxy versions. All questionnaires are adapted for the specific age groups.

This study will comply with ethic guidelines and was approved by the Life Sciences and Health Ethics Subcommittee (University of Minho) and is registered on the Portuguese authority for data collection (CNPD).

02

Conditions studied

  • Haemophilia

Browse trials for

Keywords

  • Haemophilia
  • Quality of Life
  • Distress
  • Hemarthrosis
  • Pain
03

In context

Hemophilia A

866 studies on the registry are indexed under Hemophilia A; 137 are open to participants now.

This study's enrollment of 146 is above the median of 80 across 314 observational studies indexed under Hemophilia A.

Browse Hemophilia A studies →

Lead sponsor

University of Minho is the lead sponsor of 37 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

People with Haemophilia A or B, of any age and gender, registered in the Portuguese Haemophilia Association

Inclusion criteria

  • Haemophilia A or B
  • Portuguese nationality

Exclusion criteria

Exclusion Criteria:

  • Acquired Haemophilia
  • Psychiatric or neurological deficit
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
146 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Health Related Quality of Life in Adults as assessed by A36Hemofilia-Qol

    Time frame: 1 year

  2. Health Related Quality of Life in Children as assessed by Canadian Haemophilia Outcomes-Kids Life Assessment Tool

    Health Related Quality of Life in Children

    Time frame: 1 year

  3. Pain Intensity

    Pain Questionnaire developed specifically for this investigation to assess PWH (based on Wallny's Pain Questionnaire for PWH and Brief Pain Inventory).

    Time frame: 1 year

  4. Pain Location

    Pain Questionnaire developed specifically for this investigation to assess PWH (based on Wallny's Pain Questionnaire for PWH and Brief Pain Inventory).

    Time frame: 1 year

  5. Pain Duration

    Pain Questionnaire developed specifically for this investigation to assess PWH (based on Wallny's Pain Questionnaire for PWH and Brief Pain Inventory).

    Time frame: 1 year

Secondary outcomes

  1. Total score of Haemophilia-related functional limitations as assessed by Haemophilia Activities List (HAL) and Pediatric HAL

    Time frame: 1 year

  2. Anxiety score as assessed by PROMIS-Anxiety Short Form v1.0

    Assessmet of Anxiety

    Time frame: 1 week

  3. Depression score as assessed by PROMIS-Depression Short Form v1.0

    Time frame: 1 week

  4. Illness Perception as assessed by IPQ-R

    Time frame: 1 year

  5. Pain Catastrophizing as assessed by CSQ - Catastrophizing Subscale

    Time frame: 1 year

  6. Number of Joint Bleeds

    Time frame: 1 year

  7. Presence of inibitors

    Time frame: 1 year

  8. Number of target joints

    Time frame: 1 year

  9. Type of sports practiced by PWH

    Time frame: 1 year

07

Study locations

1 site
  • Life and Health Sciences Research Institute
    Braga, 4710-057, Portugal
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 24, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02870114
Lead sponsor
University of Minho
Collaborators
Hospital Sao Joao, Portuguese hemophilia association and other congenital coagulopathies
Responsible party
Patrícia Ribeiro Pinto (Post-doctoral fellow, University of Minho) — Principal investigator
First posted
Aug 17, 2016
Start date
Sep 2016
Primary completion
May 22, 2017
Completion
May 22, 2017
Last update
May 24, 2017

Study contacts

Patrícia R Pinto, PhD
principal investigator · Life and Health Sciences Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion